# Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients

> **NCT04449380** · PHASE2 · TERMINATED · sponsor: **Emanuele Bosi** · enrollment: 56 (actual)

## Conditions studied

- COVID-19 Virus Infection

## Interventions

- **DRUG:** Interferon-ß-1a
- **COMBINATION_PRODUCT:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT04449380
- **Lead sponsor:** Emanuele Bosi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-02
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-03-30
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04449380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04449380, "Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04449380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*